Viveve Medical Inc
OTC:VIVE

Watchlist Manager
Viveve Medical Inc Logo
Viveve Medical Inc
OTC:VIVE
Watchlist
Price: 0.0002 USD Market Closed
Market Cap: $2.1k

Viveve Medical Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Viveve Medical Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Viveve Medical Inc
OTC:VIVE
Research & Development
-$8.7m
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
-15%
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
-6%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.8B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
No Stocks Found

Viveve Medical Inc
Glance View

Market Cap
2.1k USD
Industry
Health Care

Viveve Medical, Inc. engages in the design, development, manufacture, and marketing of platform medical technology. The company is headquartered in Englewood, Colorado and currently employs 47 full-time employees. The firm's CMRF technology is delivered through a radiofrequency (RF) generator, handpiece and treatment tip, that collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI), which is known as Viveve treatment. The Viveve System uses a method of delivering monopolar radiofrequency (RF) energy for treating tissue, such as Monopolar Radiofrequency Energy. The Viveve System also uses a cryogen surface cooling that enables volumetric heating of vaginal tissue. The Viveve System also uses a proprietary, controlled cryogen surface cooling that enables deep volumetric heating of vaginal tissue. The firm's subsidiary includes Viveve, Inc. and Viveve BV.

VIVE Intrinsic Value
Not Available

See Also

What is Viveve Medical Inc's Research & Development?
Research & Development
-8.7m USD

Based on the financial report for Sep 30, 2022, Viveve Medical Inc's Research & Development amounts to -8.7m USD.

What is Viveve Medical Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-15%

Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Viveve Medical Inc have been 3% over the past three years , 5% over the past five years , and -15% over the past ten years .

Back to Top